F. Casanova

1.4k total citations
17 papers, 1.1k citations indexed

About

F. Casanova is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, F. Casanova has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in F. Casanova's work include Multiple Myeloma Research and Treatments (8 papers), Asthma and respiratory diseases (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). F. Casanova is often cited by papers focused on Multiple Myeloma Research and Treatments (8 papers), Asthma and respiratory diseases (6 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). F. Casanova collaborates with scholars based in Spain, Italy and Canada. F. Casanova's co-authors include Stefano Centanni, Fabiano Di Marco, Pierachille Santus, Francesco Blasi, Massimo Verga, L. Allegra, Jesús F. San Miguel, Fernando Ortega, Rafael Jiménez and Marcos González and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and European Respiratory Journal.

In The Last Decade

F. Casanova

17 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Casanova Spain 11 453 437 266 240 208 17 1.1k
Arati V. Rao United States 19 402 0.9× 173 0.4× 179 0.7× 196 0.8× 446 2.1× 57 1.2k
Prabodh Shah United States 13 145 0.3× 150 0.3× 126 0.5× 80 0.3× 354 1.7× 22 860
Kunal K. Gandhi United States 20 576 1.3× 102 0.2× 474 1.8× 182 0.8× 198 1.0× 61 1.8k
Susan N. Rosenthal United States 20 292 0.6× 156 0.4× 94 0.4× 82 0.3× 311 1.5× 30 1.2k
Mary Woods United Kingdom 14 172 0.4× 116 0.3× 124 0.5× 64 0.3× 356 1.7× 41 1.0k
Mary J. Brames United States 17 149 0.3× 304 0.7× 128 0.5× 191 0.8× 235 1.1× 45 1.5k
Isaac Odame Canada 21 334 0.7× 124 0.3× 141 0.5× 259 1.1× 75 0.4× 49 1.2k
Denis Morin France 18 145 0.3× 228 0.5× 51 0.2× 452 1.9× 28 0.1× 51 1.4k
Henri A. Ménard Canada 17 155 0.3× 65 0.1× 71 0.3× 126 0.5× 120 0.6× 33 1.5k
Theresa B. Haddy United States 19 220 0.5× 203 0.5× 57 0.2× 114 0.5× 243 1.2× 43 1.1k

Countries citing papers authored by F. Casanova

Since Specialization
Citations

This map shows the geographic impact of F. Casanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Casanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Casanova more than expected).

Fields of papers citing papers by F. Casanova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Casanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Casanova. The network helps show where F. Casanova may publish in the future.

Co-authorship network of co-authors of F. Casanova

This figure shows the co-authorship network connecting the top 25 collaborators of F. Casanova. A scholar is included among the top collaborators of F. Casanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Casanova. F. Casanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Santus, Pierachille, et al.. (2016). Stromelysin-1 polymorphism as a new potential risk factor in progression of chronic obstructive pulmonary disease. Monaldi Archives for Chest Disease. 71(1). 15–20. 3 indexed citations
3.
Marco, Fabiano Di, Massimo Verga, F. Casanova, et al.. (2006). Anxiety and depression in COPD patients: The roles of gender and disease severity. Respiratory Medicine. 100(10). 1767–1774. 371 indexed citations
4.
Marco, Fabiano Di, J. Milic‐Emili, B. Boveri, et al.. (2002). Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD. European Respiratory Journal. 21(1). 86–94. 92 indexed citations
5.
Centanni, Stefano, Pierachille Santus, F. Casanova, et al.. (2002). Bronchodilating effect of oxitropium bromide in heart disease patients with exacerbations of COPD: double-blind, randomized, controlled study. Respiratory Medicine. 96(3). 137–141. 6 indexed citations
6.
Ortega, Juan-José, Josep‐María Ribera, Albert Oriol, et al.. (2001). Early and delayed consolidation chemotherapy significantly improves the outcome of children with intermediate risk acute lymphoblastic leukemia. Final results of the prospective randomized PETHEMA ALL-89 TRIAL.. PubMed. 86(6). 586–95. 25 indexed citations
7.
Centanni, Stefano, et al.. (2000). Psychological issues in the treatment of asthmatic patients. Respiratory Medicine. 94(8). 742–749. 80 indexed citations
8.
Centanni, Stefano, et al.. (2000). Evaluation of the effects of zafirlukast 40 mg b.i.d. in addition to preexisting therapy of high-dose inhaled steroids on symptomatic patients with reversible respiratory obstruction: preliminary data.. PubMed. 26(4). 133–8. 3 indexed citations
9.
Peralta, Raúl, et al.. (1999). [Radioimmunoscintigraphy of colorectal cancer using the anti-CEA monoclonal antibody BW 431/26. Final results].. PubMed. 18(1). 5–15. 1 indexed citations
10.
García‐Sánz, Ramón, Marcos González, Alberto Órfão, et al.. (1996). Analysis of natural killer‐associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implications. British Journal of Haematology. 93(1). 81–88. 64 indexed citations
11.
García‐Sánz, Ramón, Marcos González, Jesús María Hernández‐Rivas, et al.. (1995). Prognostic implications of DNA aneuploidy in 156 untreated multiple myeloma patients. British Journal of Haematology. 90(1). 106–112. 62 indexed citations
12.
Miguel, Jesús F. San, Ramón García‐Sánz, Marcos González, et al.. (1995). A new staging system for multiple myeloma based on the number of S- phase plasma cells. Blood. 85(2). 448–455. 85 indexed citations
13.
Miguel, Jesús F. San, Ramón García‐Sánz, Marcos González, et al.. (1995). A new staging system for multiple myeloma based on the number of S- phase plasma cells. Blood. 85(2). 448–455. 108 indexed citations
14.
Miguel, Jesús F. San, Marcos González, Jesús María Hernández‐Rivas, et al.. (1992). Lymphoid subsets and prognostic factors in multiple myeloma. British Journal of Haematology. 80(3). 305–309. 77 indexed citations
15.
Miguel, Jesús F. San, Manuel Moro, Jesús María Hernández‐Rivas, et al.. (1992). Increased expression of natural‐killer‐associated and activation antigens in multiple myeloma. American Journal of Hematology. 39(2). 84–89. 41 indexed citations
16.
Ortega, Fernando, et al.. (1992). [Utility of the examination of plasma-cell morphology in the study of multiple myeloma].. PubMed. 37(3). 175–9. 1 indexed citations
17.
Miguel, Jesús F. San, Fernando Ortega, Rafael Jiménez, et al.. (1991). Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease. British Journal of Haematology. 77(2). 185–190. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026